![Mary Spellman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mary Spellman
Presidente presso Panclarity LLC
Profilo
Mary C.
Spellman is currently the Director of Women's Dermatologic Society and a Member-Editorial Board of American Academy of Dermatology.
She is also the Chief Medical Officer of Castle Creek Biosciences, Inc. and the President of Panclarity LLC.
In the past, she has worked as a Senior Medical Director at Biogen, Inc., Senior Director-Medical Research at IDEC Pharmaceuticals Corp., Director-Clinical Research at the University of California San Diego, Medical Director at Novartis Pharmaceuticals Corp., Head-Dermatology & Drug Development at TG Therapeutics, Inc., Vice President-Clinical Research at Connetics Corp., and Chief Medical Officer & Senior VP-Development at Revance Therapeutics, Inc. She was also the Chief Medical Officer of Menlo Therapeutics, Inc. from 2018 to 2019.
Dr. Spellman received her undergraduate degree from Loyola University of Chicago and her doctorate from The Medical College of Wisconsin, Inc.
Posizioni attive di Mary Spellman
Società | Posizione | Inizio |
---|---|---|
Women's Dermatologic Society | Direttore/Membro del Consiglio | 27/06/2011 |
American Academy of Dermatology
![]() American Academy of Dermatology Miscellaneous Commercial ServicesCommercial Services American Academy of Dermatology is the largest and most influential dermatology group in the United States. The private company is based in the United States and has subsidiaries in various locations. The American company provides resources on membership, education, practice management, publications, and clinical care for dermatologists. The company also offers information for patients and the public on skin, hair, and nail conditions. Elizabeth Usher has been the CEO of the company since 2019. | Corporate Officer/Principal | 27/06/2011 |
Castle Creek Biosciences, Inc.
![]() Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Direttore Tecnico/Scientifico/R&S | 01/01/2020 |
Panclarity LLC | Presidente | - |
Precedenti posizioni note di Mary Spellman
Società | Posizione | Fine |
---|---|---|
VYNE THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 31/05/2019 |
IDEC Pharmaceuticals Corp.
![]() IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Direttore/Membro del Consiglio | - |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Direttore Tecnico/Scientifico/R&S | - |
BIOGEN INC. | Direttore Tecnico/Scientifico/R&S | - |
REVANCE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Mary Spellman
Loyola University of Chicago | Undergraduate Degree |
The Medical College of Wisconsin, Inc. | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 3 |
---|---|
BIOGEN INC. | Health Technology |
TG THERAPEUTICS, INC. | Health Technology |
REVANCE THERAPEUTICS, INC. | Health Technology |
Aziende private | 8 |
---|---|
Connetics Corp.
![]() Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Health Technology |
Menlo Therapeutics, Inc.
![]() Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Bridgewater, CA. | Health Technology |
IDEC Pharmaceuticals Corp.
![]() IDEC Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology IDEC Pharmaceuticals Corp. used to develop and commercialize targeted immunotherapies for the treatment of cancer and autoimmune diseases. The company’s products used to act chiefly through immune system mechanisms, exerting their effect by binding to specific, readily targeted immune cells in the patient’s blood or lymphatic system. The company was headquartered in San Diego, CA. | Health Technology |
Novartis Pharmaceuticals Corp.
![]() Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
American Academy of Dermatology
![]() American Academy of Dermatology Miscellaneous Commercial ServicesCommercial Services American Academy of Dermatology is the largest and most influential dermatology group in the United States. The private company is based in the United States and has subsidiaries in various locations. The American company provides resources on membership, education, practice management, publications, and clinical care for dermatologists. The company also offers information for patients and the public on skin, hair, and nail conditions. Elizabeth Usher has been the CEO of the company since 2019. | Commercial Services |
Women's Dermatologic Society | |
Castle Creek Biosciences, Inc.
![]() Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Health Technology |
Panclarity LLC |
- Borsa valori
- Insiders
- Mary Spellman